RADIOPROTECTIVE EFFECTS OF THE IMMUNOMODULATOR AS101

被引：0
|
作者：
KALECHMAN, Y
ALBECK, M
ORON, M
SOBELMAN, D
GURWITH, M
SEGHAL, SN
SREDNI, B
机构：
[1] BAR ILAN UNIV,DEPT LIFE SCI,CANC AIDS IMMUNOL RES INST,IL-52900 RAMAT GAN,ISRAEL
[2] WYETH AYERST RES LABS,RADNOR,PA 19087
来源：
JOURNAL OF IMMUNOLOGY | 1990年 / 145卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1512 / 1517
页数：6
相关论文
共 50 条
  • [31] Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101
    Kalechman, Y
    Sredni, B
    Weinstein, T
    Freidkin, I
    Tobar, A
    Albeck, M
    Gafter, U
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (03): : 620 - 630
  • [32] Suppression of interleukin 10 by the immunomodulator AS101 inhibits development of autoantibodies and glomerulonephritis in systemic lupus erythematosus (SLE).
    Kalechman, Y
    Gafter, U
    Albeck, M
    Sredni, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2503 - A2503
  • [33] The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models
    Sredni, B
    Xu, RH
    Albeck, M
    Gafter, U
    Gal, R
    Shani, A
    Tichler, T
    Shapira, J
    Bruderman, I
    Catane, R
    Kaufman, B
    Whisnant, JK
    Mettinger, KL
    Kalechman, Y
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (01) : 97 - 103
  • [34] IMMUNOLOGICAL EFFECTS OF AS101 IN THE TREATMENT OF CANCER-PATIENTS
    SHANI, A
    TICHLER, T
    CATANE, R
    GURWITH, M
    ROZENSZAJN, LA
    GEZIN, A
    LEVI, E
    SCHLESINGER, M
    KALECHMAN, Y
    MICHLIN, H
    SHALIT, F
    ENGELSMAN, E
    FARBSTEIN, H
    FARBSTEIN, M
    ALBECK, M
    SREDNI, B
    NATURAL IMMUNITY AND CELL GROWTH REGULATION, 1990, 9 (03) : 182 - 190
  • [35] The immunomodulator AS101 restores TH1 type of response suppressed by Babesia rodhaini in BALB/c mice
    Rosenblatt-Bin, H
    Kalechman, Y
    Vonsover, A
    Xu, RH
    Da, JP
    Shalit, F
    Huberman, M
    Klein, A
    Strassmann, G
    Albeck, M
    Sredni, B
    CELLULAR IMMUNOLOGY, 1998, 184 (01) : 12 - 25
  • [36] AS101 antidepressant-like effects in rat models for depression
    Saida, H.
    Gersner, R.
    Zangen, A.
    Sredni, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S50 - S50
  • [37] AS101, an interesting multipotent drug
    Avendano Lopez, Ma del Carmen
    ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA, 2013, 79 (02): : 200 - 206
  • [38] Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: Role in Th1 predominance and in the antitumoral effects of AS101.
    Kalechman, Y
    Tichler, T
    Shani, A
    Albeck, M
    Sredni, B
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 392 - 392
  • [39] Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo
    Liu, Haifeng
    Zhang, Ying
    Zhong, Zeyong
    Gong, Yanchun
    Yu, Pingting
    Yang, Yuhan
    Zhang, Yichi
    Zhou, Tieli
    Chen, Lijiang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (04)
  • [40] Delay in the onset of SLE following treatment with the immunomodulator AS101:: Association with IL-10 inhibition and increase in TNFα levels
    Kalechman, Y
    Gafter, U
    Albeck, M
    Sredni, B
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 475 - 475
12345